![]() |
市场调查报告书
商品编码
1722440
2025-2033年医用导管市场报告(依产品、结构、应用、最终用户和地区)Medical Tubing Market Report by Product, Structure, Application, End User, and Region 2025-2033 |
2024年全球医用导管市场规模达145亿美元。展望未来, IMARC Group预计到2033年市场规模将达到248亿美元,2025-2033年期间的成长率(CAGR)为5.87%。癌症、关节炎和心血管疾病的发生率不断上升,以及导管插入术中医用导管的广泛使用,推动了市场的成长。
主要市场驱动因素:技术进步、老年人口增加、慢性病发病率激增以及家庭医疗保健市场的扩张正在刺激行业成长。此外,更高的医疗保健支出支持采用先进的医疗技术,从而进一步支持医疗管道市场的需求。
主要市场趋势:医疗管设备小型化的倾向日益增强、客製化和个人化的需求、对病患舒适度和安全性的关注等是一些主要市场趋势。此外,人们对使用生物相容性和生物可吸收材料製造医疗管的兴趣日益浓厚。这些材料最大限度地降低了不良反应和组织损伤的风险,并且可以随着时间的推移在体内安全降解,无需进行移除手术,从而进一步促进行业成长。
地理格局:根据报告,北美占据最大的市场份额。北美是医疗技术创新的中心,重点是开发涉及医疗管的先进医疗设备。此外,管道材料、製造技术和设计的不断进步也促进了市场的成长,提高了医疗管道的性能、安全性和功效。
竞争格局:一些领先的医疗导管市场公司包括 ATAG spa、Avient Corporation、Bentec Medical、Hitachi Ltd.、Microlumen Inc.、NewAge Industries Inc.、Nordson Corporation、Optinova、Spectrum Plastics Group、TE Connectivity Ltd.、Trelleborg AB 和 Vanguard Products Corporation 等。
挑战与机会:严格的监管要求、成本压力、对产品品质和安全日益增长的关注以及感染风险是市场面临的一些主要挑战。然而,个人化医疗趋势的日益增长为根据个别患者需求量身定制的医疗管解决方案开闢了众多医疗管市场机会。 3D 列印等技术能够根据患者特定的解剖差异和临床要求生产客製化医疗管,进一步增加市场需求。
微创手术需求不断成长
对医学侵入性手术的需求不断增加确实对医用导管市场的成长做出了重大贡献。例如,根据 2022 年 1 月的文章《未来微创手术的微电子导管》,导管在微创手术中发挥重要作用,因为它们可以轻鬆去除血栓、植入植入物或精确地在需要的地方给药。它们的设计也对患者特别温和。此外,医用导管在医疗保健环境中的各种应用中发挥着至关重要的作用,包括外科手术、诊断过程、药物传输系统和静脉治疗等。随着医疗技术的不断进步,专业化、先进医疗导管的需求也不断增加。例如,2023 年 9 月,全球先进聚合物解决方案提供商 Zeus 创造了 AbsorvTM XSE 定向管,这是其生物可吸收产品系列的最新成员。 Absorv XSE 是一个高度可调节的设计平台,为永久植入人体的金属物品提供了替代品。它适用于多种树脂并具有更大的尺寸范围。此外,全球人口老化和慢性病的盛行率上升也增加了对侵入性手术的需求。心血管疾病、癌症和神经系统疾病等疾病通常需要依靠医疗管道进行精确治疗。例如,根据 MD 安德森癌症中心 2024 年 4 月发表的文章,如果癌症患者因头部或颈部癌症而吞嚥困难,或在癌症治疗(包括手术、化疗和放射治疗)之前或期间营养不良,则可能需要餵食管。这些因素进一步促进了医疗导管市场份额的成长。
老年人口不断增加
由于预期寿命延长,老龄人口正在显着增加。例如,根据世界卫生组织的数据,60岁及以上人口的数量正在增加。 2019年,60岁以上人口已达10亿人。到2030年,这一数字将上升到14亿,到2050年将上升到21亿。随着老龄人口的成长,对各种医疗服务和设备的需求也在增加,包括那些使用医用导管的服务和设备。医用导管用途广泛,例如静脉 (IV) 管、导管、呼吸管和餵食管,老年人通常需要这些导管来治疗各种健康状况。根据美国国家医学图书馆发表的一篇文章,鼻胃管餵食通常用于老年患者(65岁以上)因吞嚥困难和营养不良而进行。老年人的吞嚥困难通常由多种因素造成。此外,老年人口往往需要持续的医疗照护和支持,从而导致医疗导管产品的消费量增加。此外,医疗技术的进步促进了用于不同医疗程序的专用管道的开发,从而进一步增加了医疗管道市场的收入。例如,2022 年 12 月,科德宝医疗在 CPhl 和 PMEC 印度展会上推出了新产品 HelixFlex。本产品是一种高纯度热塑性弹性体 TPE 管,专门用于生物製药流体输送应用。
慢性病发生率激增
心血管、糖尿病、癌症等慢性疾病的发生率正在大幅上升,进一步推动了对医用导管的需求。根据卫生指标与评估研究所2023年6月发布的报告,在每个国家,各个年龄层的男性、女性和儿童都受到糖尿病的影响,全球有超过5亿人患有糖尿病。未来30年,预计这一数字将增加一倍以上,达到13亿人,而且每个国家的人口都会增加。医用导管在输送药物、液体和营养以及监测和管理这些状况方面发挥着至关重要的作用。此外,许多慢性病需要持续用药来控制症状、控制病情进展或预防併发症。这些因素正在影响医用导管市场的近期价格。医用导管,例如静脉 (IV) 管和输液器,有助于安全有效地输送药物,包括化疗药物、胰岛素、抗生素和止痛药。例如,根据帕金森基金会 2022 年的资料更新,预计美国每年将有 9 万人被诊断出患有帕金森氏症,到 2030 年,预计约有 120 万美国人将患有这种疾病。与此一致,当某人患有这种疾病时,控制症状会变得困难,因为脑细胞不会吸收左旋多巴和储存多巴胺。在此期间服药变得至关重要,输液疗法可以更持续地输送药物,并提供更一致、更可靠的症状缓解。这些因素进一步对医疗导管市场预测产生了正面影响。
The global medical tubing market size reached USD 14.5 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 24.8 Billion by 2033, exhibiting a growth rate (CAGR) of 5.87% during 2025-2033. The rising prevalence of cancer, arthritis, and cardiovascular conditions, along with the widespread usage of medical tubing in catheterization, is propelling the market growth.
Major Market Drivers: Technological advancements, rising geriatric population, surging incidence of chronic diseases, and expanding home healthcare market are stimulating the industry growth. Additionally, higher healthcare expenditures support the adoption of advanced medical technologies, thereby further supporting the medical tubing market demand.
Key Market Trends: The growing inclination towards miniaturization of medical tube devices, demand for customization and personalization, focus on patient comfort and safety, etc., are some of the key market trends. Moreover, there's increasing interest in the use of biocompatible and bioresorbable materials for medical tubes. These materials minimize the risk of adverse reactions and tissue damage, and they can degrade safely within the body over time, eliminating the need for removal procedures, thereby further escalating the industry growth.
Geographical Landscape: According to the report, North America accounted for the largest market share. North America is a hub for medical technology innovation, with a strong focus on developing advanced medical devices, involving medical tubes. In addition, continuous advancements in tube materials, manufacturing techniques, and design contribute to the growth of the market by improving the performance, safety, and efficacy of medical tubes.
Competitive Landscape: Some of the leading medical tubing market companies are ATAG spa, Avient Corporation, Bentec Medical, Hitachi Ltd., Microlumen Inc., NewAge Industries Inc., Nordson Corporation, Optinova, Spectrum Plastics Group, TE Connectivity Ltd., Trelleborg AB, and Vanguard Products Corporation, among many others.
Challenges and Opportunities: Strict regulatory requirements, cost pressures, rising concern for product quality and safety, and infection risk are some of the key challenges that the market is facing. However, the rising inclination towards personalized medicine opens up numerous medical tubing market opportunities for customized medical tube solutions tailored to individual patient needs. Technologies like 3D printing enable the production of bespoke medical tubes based on patient-specific anatomical variations and clinical requirements, thereby further escalating the market demand.
Rising Demand for Minimally Invasive Procedures
The increasing demand for medically invasive procedures indeed contributes significantly to the growth of the medical tubing market. For instance, according to the January 2022 article ""Microelectronic Catheter for Minimally Invasive Surgery of the Future,"" catheters play a major role in minimally invasive surgery because they make it easy to remove blood clots, insert implants, or administer drugs precisely where they are needed. They are also designed to be especially gentle on patients. Moreover, medical tubing plays a crucial role in various applications within healthcare settings, including surgical procedures, diagnostic processes, drug delivery systems, and intravenous therapies, among others. As advancements in medical technology continue to evolve, the need for specialized and advanced medical tubing also rises. For instance, in September 2023, Zeus, an advanced polymer solutions provider around the world, created AbsorvTM XSE oriented tubing, the newest addition to its line of bioabsorbable products. Absorv XSE is a highly adjustable platform for design that offers an alternative to metallic items implanted permanently in the human body. It is available in a variety of resins and increased size ranges. Moreover, the aging population and the increasing prevalence of chronic diseases worldwide contribute to the demand for invasive procedures. Conditions, such as cardiovascular diseases, cancer, and neurological disorders often require interventions that rely on medical tubing for precise delivery of treatments. For instance, according to the article published by MD Anderson Cancer Center in April 2024, cancer patients might need a feeding tube if they have trouble swallowing due to cancer in the head or neck area or are malnourished before or during cancer treatment, including surgery, chemotherapy, and radiation therapy. These factors are further contributing to the medical tubing market share.
Increasing Geriatric Population
The aging population is increasing significantly owing to longer life expectancy. For instance, according to the World Health Organization, the number of people aged 60 and up in the population is increasing. In 2019, there were one billion people aged 60 and over. This figure will rise to 1.4 billion by 2030, and 2.1 billion by 2050. As the elderly population grows, there's an increased demand for various medical services and devices, including those that utilize medical tubing. Medical tubing is used in a wide range of applications, such as intravenous (IV) lines, catheters, respiratory tubing, and feeding tubes, which are commonly required by older individuals for managing various health conditions. According to an article published by the National Library of Medicine, nasogastric feeding is often used in elderly patients (over the age of 65) due to dysphagia and malnutrition. Dysphagia in older adults is usually multifactorial. Moreover, the aging population often requires ongoing medical care and support, leading to higher consumption of medical tubing products. Additionally, advancements in medical technology have led to the development of specialized tubing for different medical procedures, thereby further bolstering the medical tubing market revenue. For instance, in December 2022, Freudenberg Medical launched a new product, HelixFlex, at the CPhl and PMEC India. The product is a high-purity thermoplastic elastomer TPE tubing intended for use in biopharmaceutical fluid transfer applications.
Surging Incidences of Chronic Diseases
The incidence of chronic diseases such as cardiovascular, diabetes, cancer, etc., is experiencing a significant surge, thereby further driving the demand for medical tubing. According to a report published by the Institute for Health Metrics and Evaluation in June 2023, in every country, men, women, and children of all ages are affected by diabetes, which affects more than half a billion people globally. In the next 30 years, that figure is expected to more than double to 1.3 billion people, with an increase in every country. Medical tubing plays a crucial role in the delivery of medications, fluids, and nutrition, as well as in monitoring and managing these conditions. Moreover, many chronic conditions require ongoing medication to manage symptoms, control disease progression, or prevent complications. These factors are influencing the medical tubing market's recent prices. Medical tubing, such as intravenous (IV) lines and infusion sets, facilitates the safe and efficient delivery of medications, including chemotherapy drugs, insulin, antibiotics, and pain relievers. For instance, according to the Parkinson's Foundation's 2022 data update, 90,000 individuals in the U.S. are expected to receive a PD diagnosis each year, and by 2030, about 1.2 million Americans are expected to have the disease. In line with this, it gets difficult to control the symptoms when someone is suffering from this disease as brain cells don't absorb levodopa and store dopamine. It becomes crucial to take the drug during the time, infusion therapy delivers medication more continuously and provides more consistent and reliable symptom relief. These factors are further positively influencing the medical tubing market forecast.
Currently, polyvinyl chloride holds the majority of the total market share
According to the medical tubing market overview, polyvinyl chloride (PVC) medical tubing finds widespread usage across various medical applications due to its favorable properties, such as flexibility, durability, biocompatibility, and affordability. PVC tubing is extensively used in IV therapy for delivering fluids, medications, and blood products directly into the bloodstream. It is available in various lengths and diameters to accommodate different clinical needs. As healthcare spending continues to rise globally, there's a parallel demand for PVC medical tubing. Moreover, PVC tubing is often preferred for its cost-effectiveness compared to other materials like silicone or polyurethane, especially in applications where disposable tubing is used, further driving its adoption. For instance, in May 2021, Benvic, a PVC compound and ecological biopolymers specialist, announced that it would use its ModenPlast subsidiary in Northern Italy to look for material synergies and innovative products for the global medical markets.
Single-Lumen tubing consists of a single hollow channel and is commonly used in applications where a single fluid or gas needs to be transported, such as in IV lines, oxygen delivery systems, or simple drainage tubes. While co-extruded tubing involves the simultaneous extrusion of multiple layers of materials with different properties. Moreover, multi-lumen tubing contains multiple channels within the same tube. It is commonly used in medical devices where separate channels are needed for various functions, such as in catheters with separate lumens for medication delivery. Furthermore, tapered or bump tubing is designed with a gradual decrease or increase in diameter along its length, creating a tapered or bump feature. Also, braided tubing consists of multiple layers of materials with fibers braided around the inner tube. This construction provides increased strength, kink resistance, and burst pressure compared to non-braided tubing.
Bulk disposable tubing currently exhibits a clear dominance in the market
As per the medical tubing market overview, bulk disposable tubing offers cost advantages due to its mass production and single-use nature. Healthcare facilities can purchase these tubes in large quantities at competitive prices, reducing overall expenses. Moreover, disposable tubing minimizes the risk of cross-contamination and nosocomial infections compared to reusable tubing. After a single use, the tubing is discarded, eliminating the need for sterilization and reducing the chances of transmitting pathogens between patients. Furthermore, this tubing meets stringent regulatory requirements for medical devices, ensuring adherence to quality and safety standards. Manufacturers produce disposable tubing using materials that comply with regulatory standards for biocompatibility and sterility, providing reassurance to healthcare providers and patients. For instance, in November 2020, Olympus partnered with Ruhof Corporation to launch the Olympus Procedure Kits, and Hybrid Tubing, two new single-use and single-day devices that alleviate the possibility of cross-contamination.
Currently, hospitals and clinics account for the largest market share
Hospitals and clinics are primary settings for patient care and treatment, where medical tubing is extensively used in various medical procedures and therapies. From intravenous therapy and respiratory support to surgical interventions and diagnostic procedures, medical tubing plays a vital role in delivering fluids, medications, and gases to patients. Moreover, hospitals and clinics require medical tubing for a diverse range of applications across different departments and specialties. This includes intravenous administration sets, catheters, drainage tubes, endotracheal tubes, feeding tubes, and more. Each department within a hospital, such as emergency, intensive care, surgery, and obstetrics, relies on specific types of tubing tailored to their clinical needs. For instance, in November 2023, the Medical Research Council awarded the University of Nottingham £1.1 million to conduct human trials for the world's first endotracheal tube integrated with an optical fiber sensor.
North America currently dominates the global market
The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America currently dominates the global market.
According to the medical tubing market statistics, North America boasts one of the highest healthcare expenditures globally. The continuous rise in healthcare spending, driven by factors such as an aging population, increasing prevalence of chronic diseases, and advancements in medical technology, contribute significantly to the growth of the medical tubing market. The region is a hub for medical innovations and technological advancements. Moreover, manufacturers are constantly developing new materials, designs, and manufacturing processes to enhance the performance, biocompatibility, and safety of medical tubing. These advancements attract investment and drive the market growth as healthcare providers seek cutting-edge solutions. For instance, in March 2022, Shockwave Medical, Inc., received FDA permission and introduced the Shockwave M5+ peripheral IVL catheter. The Shockwave M5+ catheter is specifically developed to reduce Intravascular Lithotripsy (IVL) treatment time, offer alternate access options, and expand IVL therapy to patients with bigger vessel diameters.
The market research report has provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the key players in the market include: